US President Donald Trump has threatened to impose a major tariff on pharmaceutical imports, sparking concerns for India’s lucrative generics export industry. The global pharmaceutical industry was initially exempt, but this could change if domestic production becomes more feasible. With no immediate replacement in sight, the impact on India’s economy is significant, particularly given its reliance on exports to the US market.
Source: https://www.nytimes.com/2025/04/09/business/trump-tariffs-pharmaceuticals-india.html